Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL1608734 | 0.98 | ALDH1A1 (0.32) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL442699 | 0.98 | ALDH1A1 (0.32) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| SCHEMBL819057 | 0.93 | — | — | |
| SCHEMBL18287206 | 0.92 | — | — | |
| SCHEMBL29603795 | 0.89 | ALDH1A1 (0.34) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| SCHEMBL29603410 | 0.88 | ALDH1A1 (0.33) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| Bromide SCHEMBL4539689 | 0.88 | ALDH1A1 (0.33) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| SCHEMBL21722392 | 0.88 | ALDH1A1 (0.33) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL17783834 | 0.84 | L3MBTL1 (0.30) | — | |
| SCHEMBL6098447 | 0.84 | ALDH1A1 (0.31) | ALDH1A1POLBMAPTHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250109115-A1 | METHOD FOR PREPARING A CYCLIC ANHYDRIDE FROM AN UNSATURATED CARBOXYLIC ACID | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2025-04-03 | — | — | US | claimed |
| WO-2025045850-A1 | METHOD FOR PREPARING HYDROBORANES BY HYDROGENOLYSIS OF (PSEUDO-)HALOBORANES | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2025-03-06 | — | — | WO | claimed |
| EP-4430033-A1 | METHOD FOR PREPARING A CYCLIC ANHYDRIDE FROM AN UNSATURATED CARBOXYLIC ACID | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2024-09-18 | — | — | EP | claimed |
| US-11912731-B2 | Use of silylated formiates as hydrosilane equivalents | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2024-02-27 | — | — | US | claimed |
| WO-2023083828-A1 | METHOD FOR PREPARING A CYCLIC ANHYDRIDE FROM AN UNSATURATED CARBOXYLIC ACID | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2023-05-19 | — | — | WO | claimed |
| US-20210292345-A1 | Use of Silylated Formiates as Hydrosilane Equivalents | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2021-09-23 | — | — | US | claimed |
| US-11084777-B2 | Method for preparing alkylamines | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2021-08-10 | — | — | US | claimed |
| EP-3374363-B1 | METHOD FOR PREPARING METHOXYBORANES AND FOR PRODUCING METHANOL | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2020-04-01 | — | — | EP | claimed |
| EP-3507292-A1 | USE OF SILYLATED FORMIATES AS HYDROSILANE EQUIVALENTS | Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) | 2019-07-10 | — | — | EP | claimed |
| US-20190084917-A1 | Method for Preparting Alkylamines | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2019-03-21 | — | — | US | claimed |
| EP-2803356-A1 | Method for treating neurological disorders with imidazolium and imidazolinium compounds | Agency for Science, Technology and Research (SG) | 2014-11-19 | — | — | EP | claimed |
| US-8877971-B2 | Method for preparing formamide compounds | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2014-11-04 | — | — | US | claimed |
| EP-2694469-A2 | METHOD FOR PREPARING FORMAMIDE COMPOUNDS | Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) | 2014-02-12 | — | — | EP | claimed |
| US-20140018576-A1 | Method for Preparing Formamide Compounds | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2014-01-16 | — | — | US | claimed |
| WO-2013182991-A1 | METHOD FOR PREPARING METHYLATED AMINES | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2013-12-12 | — | — | WO | claimed |
| WO-2012137152-A2 | METHOD FOR PREPARING FORMAMIDE COMPOUNDS | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2012-10-11 | — | — | WO | claimed |
| US-20110178040-A1 | METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-07-21 | — | — | US | claimed |
| US-20110028513-A1 | METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-02-03 | — | — | US | claimed |
| EP-2271338-A1 | METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | Agency for Science, Technology And Research (SG) | 2011-01-12 | — | — | EP | claimed |
| WO-2009123569-A1 | METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-10-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210292345-A1 | Use of Silylated Formiates as Hydrosilane Equivalents | PFAS, EPM2A, CYP2F1 | ALDH1A1 112/4885POLB 2521/4885MAPT 666/4885 |
| US-20110028513-A1 | METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | SMN1; SMN2, INA, NLN | ALDH1A1 2486/4885POLB 4811/4885MAPT 76/4885 |
| US-11912731-B2 | Use of silylated formiates as hydrosilane equivalents | PFAS, EPM2A, CYP2F1 | ALDH1A1 112/4885POLB 2521/4885MAPT 666/4885 |
| US-20110178040-A1 | METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | MMP1, MYLK, MMP8 | ALDH1A1 1225/4885POLB 4512/4885MAPT 4680/4885 |
| US-11084777-B2 | Method for preparing alkylamines | ALKBH2, ACR, ALKBH1 | ALDH1A1 880/4885POLB 1421/4885MAPT 3425/4885 |
| US-20140018576-A1 | Method for Preparing Formamide Compounds | PFAS, F2, F8 | ALDH1A1 511/4885POLB 1413/4885MAPT 1348/4885 |
| US-20250109115-A1 | METHOD FOR PREPARING A CYCLIC ANHYDRIDE FROM AN UNSATURATED CARBOXYLIC ACID | CA7, CA6, ASIC1 | ALDH1A1 823/4885POLB 3900/4885MAPT 3692/4885 |
| US-20190084917-A1 | Method for Preparting Alkylamines | ALKBH2, ACR, ALKBH5 | ALDH1A1 827/4885POLB 1025/4885MAPT 3566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.